mucormycosis – mycolab.ai

A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori

mycolabadmin

Researchers developed a silkworm-based model to study mucormycosis, a deadly fungal infection. The model reproduces the same disease patterns and risk factors seen in humans, including effects of steroids and iron levels. Importantly, it successfully predicted how well antifungal drugs work against the infection, offering a faster and more ethical alternative to mammal testing for developing new treatments.

Continuous debridement combined with short-term posaconazole therapy for cutaneous mucormycosis caused by Rhizopus oryzae infection secondary to acute myeloid leukemia: a case report

mycolabadmin

An 80-year-old patient with acute myeloid leukemia developed a serious fungal skin infection caused by Rhizopus oryzae on his lower leg. Doctors treated the infection by repeatedly cleaning out the infected tissue and giving him an antifungal medication called posaconazole for just one week. Despite the short treatment duration due to cost concerns, the patient’s wound gradually healed over four months through continued surgical care, showing that sometimes focused surgical treatment can be as effective as long-term medication.

Detection and diagnostic process of liver abscess secondary to chemotherapy by mucor indicus in a patient with acute leukemic disease: case report

mycolabadmin

A 60-year-old man with acute leukemia developed a serious fungal infection in his liver caused by Mucor indicus after receiving chemotherapy that weakened his immune system. Doctors identified the infection through tissue samples and genetic testing, then treated him successfully with antifungal medications amphotericin B and posaconazole. This case highlights the importance of early detection and proper diagnosis of rare fungal infections in cancer patients undergoing chemotherapy.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Scientists studied three types of dangerous fungi that cause serious infections in people with weak immune systems. They looked at the outer coating of these fungi cells, which is what the body’s immune system first encounters during infection. They found that this coating contains multiple types of sugar-like substances that trigger strong inflammatory responses in immune cells. Understanding these fungi better could help develop better treatments for these serious infections.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Mucormycosis is a dangerous fungal infection that kills many immunocompromised patients. Researchers analyzed the outer layer (cell wall) of three common disease-causing fungi and discovered that their surfaces contain sugar-like molecules that trigger strong inflammatory responses from the immune system. This excessive inflammation may actually contribute to the disease’s severity, suggesting that controlling inflammation alongside antifungal treatment might improve patient outcomes.

Disseminated Lichtheimia ramosa infection in a Japanese Black calf

mycolabadmin

A young cow developed a severe fungal infection caused by Lichtheimia ramosa, a rare type of mold. The infection spread throughout the cow’s body, affecting the liver and digestive system. The cow had an underdeveloped immune system (thymus hypoplasia) and was given multiple antibiotics for weeks, which actually made the fungal infection worse by killing normal protective bacteria. Despite various treatments, the cow’s condition worsened and it had to be euthanized.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Researchers studied three dangerous fungi that cause serious infections called mucormycosis. They examined the outer coating of these fungi, called the cell wall, which is made of sugar-like molecules called polysaccharides. When these fungi were exposed to human immune cells, they triggered strong inflammatory responses. Understanding these fungal components could help develop better treatments and vaccines for this life-threatening infection.

Epidemiology of mucormycosis in COVID-19 patients in northwest Iran: Rhizopus arrhizus as the predominant species

mycolabadmin

During the COVID-19 pandemic, a dangerous fungal infection called mucormycosis was found in 63 patients in northwestern Iran. The infection was caused mainly by a fungus called Rhizopus arrhizus and most commonly affected the sinuses and brain. Most patients had been given high-dose steroids to treat their COVID-19, which weakened their immune systems and increased their risk of this serious fungal infection, especially those with diabetes.

Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

mycolabadmin

A 74-year-old man with blood cancer developed a serious fungal skin infection caused by Mucorales while taking multiple targeted cancer drugs. The infection appeared as a darkening ulcer on his ankle that rapidly worsened. Doctors diagnosed it using a skin biopsy showing characteristic fungal structures, though standard fungal tests came back negative. The patient required amputation of his leg below the knee to remove all the infected tissue, along with antifungal medications, and ultimately recovered.

A Rare Battle: Multidisciplinary Care for a Child with Rhino-Orbital Cerebral Mucormycosis in Somali Region of Ethiopia

mycolabadmin

A 12-year-old girl with poorly controlled diabetes developed a serious fungal infection in her sinuses and eye that spread to her brain. Despite the infection being extremely dangerous, doctors successfully treated her using multiple approaches including antifungal medication, surgery to remove infected tissue, and careful management of her blood sugar. She recovered and went home, though she lost vision in one eye.

Research Keyword: mucormycosis